Endoscopic Injection Needle Market Size, Share, Growth, and Industry Analysis, By Type ( Diameter 19G,Diameter 22G,Diameter 23G,Diameter 25G,Diameter 26G,Others ), By Application ( Hospitals,Clinics,Others ), Regional Insights and Forecast to 2035

Endoscopic Injection Needle Market Market Overview

GlobalEndoscopic Injection Needle Market size is anticipated to be valued at USD 492.35 million in 2026, with a projected growth to USD 735.01 million by 2035 at a CAGR of 4.6%.

The Endoscopic Injection Needle Market Market is a critical segment within gastrointestinal and minimally invasive surgical devices, driven by increasing endoscopic procedures exceeding 75 million annually worldwide. These devices are essential for delivering sclerotherapy agents, hemostatic solutions, and lifting agents during procedures. Needle diameters range from 19G to 26G, supporting varied clinical applications. Hospitals account for approximately 62% of device usage due to high procedural volumes. Technological improvements have enhanced needle flexibility and penetration accuracy by 28%, reducing procedural complications. Single-use disposable needles dominate adoption with 71% share, minimizing infection risks and improving patient safety standards globally.

The United States Endoscopic Injection Needle Market Market demonstrates strong adoption due to advanced healthcare infrastructure and high endoscopic procedure volumes exceeding 20 million annually. Hospitals dominate usage with nearly 66% share, supported by over 6,000 surgical centers performing GI procedures. Disposable needle adoption exceeds 74%, driven by strict infection control protocols. Technological advancements have improved procedural precision by 30%, enhancing clinical outcomes. The prevalence of gastrointestinal disorders affects approximately 60 million individuals, increasing demand for endoscopic treatments. Additionally, more than 45% of procedures involve therapeutic interventions requiring injection needles, reinforcing consistent market demand across healthcare facilities.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: 64% rise in gastrointestinal procedures, 52% increase in minimally invasive surgeries, 48% growth in therapeutic endoscopy adoption, 36% improvement in procedural accuracy.
• Major Market Restraint: 41% risk of needle clogging, 38% high device costs, 33% sterilization complexity, 27% procedural complications.
• Emerging Trends: 58% adoption of disposable needles, 44% increase in precision-engineered devices, 39% growth in flexible needle designs, 31% rise in AI-assisted endoscopy.
• Regional Leadership: 42% Asia-Pacific share, 28% North America share, 21% Europe share, and 9% Middle East & Africa share driven by healthcare investments and procedural volumes.
• Competitive Landscape: 54% market share held by top 5 players, 46% fragmented among regional companies, 37% focus on innovation, 32% investment in production expansion.
• Market Segmentation: Hospitals hold 62%, clinics account for 27%, others represent 11%, while 23G and 25G needles together account for 49% due to versatility and precision advantages.
• Recent Development: 47% increase in product innovation, 36% rise in regulatory approvals, 33% expansion in manufacturing facilities, 29% growth in clinical trials.

Endoscopic Injection Needle Market Market Latest Trends

The Endoscopic Injection Needle Market Market is evolving with advancements in minimally invasive technologies and increased demand for precision-based procedures. Disposable injection needles now account for approximately 71% of total usage due to infection control requirements. Flexible needle technology has improved maneuverability by 34%, allowing better access to complex anatomical areas. The integration of advanced materials has enhanced durability and reduced breakage rates by 22%. Hospitals continue to dominate demand, supported by increasing gastrointestinal procedures exceeding 75 million globally.

Additionally, AI-assisted endoscopic systems are improving procedural accuracy and reducing error rates. Outpatient procedures have increased significantly, contributing to wider adoption of compact and efficient injection devices. Manufacturers are focusing on ergonomic designs to improve handling and reduce procedural time. Continuous innovation in needle coating and sharpness is improving penetration efficiency and patient outcomes, supporting long-term market expansion.

Endoscopic Injection Needle Market Market Dynamics

DRIVER

"Rising demand for minimally invasive endoscopic procedures"

The growing preference for minimally invasive procedures is a major driver of the Endoscopic Injection Needle Market Market. Endoscopic techniques reduce recovery time and improve patient outcomes, increasing their adoption across healthcare facilities. Gastrointestinal procedures account for a significant portion of demand, with global procedure volumes exceeding 75 million annually. Hospitals represent nearly 62% of device usage due to high patient inflow and advanced infrastructure. The increasing prevalence of gastrointestinal diseases, affecting approximately 60 million individuals, further drives demand. Technological advancements have improved procedural success rates by 30%, encouraging adoption among healthcare providers. Additionally, rising awareness of early diagnosis and treatment is contributing to increased procedure volumes.

RESTRAINT

"High cost and procedural complexity"

The cost of endoscopic injection needles and associated procedures presents a significant restraint in market growth. Advanced needle designs and materials increase production costs, limiting accessibility in cost-sensitive regions. Approximately 38% of healthcare providers report cost-related constraints in adopting advanced devices. Procedural complexity also impacts adoption, requiring skilled professionals and specialized training. Around 27% of complications arise due to improper handling or device limitations. Sterilization and infection control requirements further add to operational costs. Additionally, smaller healthcare facilities face challenges in maintaining consistent supply and infrastructure, limiting market penetration.

OPPORTUNITY

"Expansion in outpatient and ambulatory care settings"

The expansion of outpatient and ambulatory care facilities presents significant growth opportunities for the market. These settings offer cost-effective and efficient treatment options, increasing patient preference. Approximately 31% of endoscopic procedures are now performed in outpatient settings, reflecting a shift in healthcare delivery. The demand for compact and easy-to-use devices is increasing, driving innovation in needle design. Technological advancements have improved device portability and efficiency, supporting adoption in smaller facilities. Additionally, government initiatives promoting accessible healthcare are encouraging the development of advanced medical devices. These trends are expected to enhance market reach and accessibility.

CHALLENGE

"Device durability and performance limitations"

Maintaining consistent device performance and durability remains a challenge in the Endoscopic Injection Needle Market Market. Needle clogging and breakage issues affect approximately 41% of procedures, impacting clinical outcomes. Material limitations and repeated usage can reduce device efficiency over time. Approximately 33% of manufacturers face challenges in balancing flexibility and strength in needle design. Ensuring precision and safety in complex procedures requires continuous innovation and quality control. Additionally, regulatory compliance and approval processes add complexity to product development. These challenges highlight the need for ongoing research and technological improvements to ensure reliability and efficiency.

Endoscopic Injection Needle Market Market Segmentation

Download FREE Sample to learn more about this report.

By Type

Diameter 19G: The 19G endoscopic injection needle segment is primarily used in procedures requiring higher fluid delivery and stronger structural support. These needles are preferred in advanced therapeutic interventions where larger injection volumes are necessary. The segment accounts for approximately 12% of total market usage, reflecting its specialized application scope. Hospitals utilize 19G needles in complex gastrointestinal procedures where stability is critical. The rigid structure supports consistent performance but limits flexibility in narrow anatomical pathways. Around 18% improvement in delivery efficiency has been observed in high-volume injection procedures using larger gauge needles. Adoption remains concentrated in high-end medical facilities with specialized capabilities. Manufacturers continue to improve material strength to enhance reliability.

Diameter 22G: The 22G segment offers a balance between flexibility and injection capacity, making it suitable for a wide range of endoscopic procedures. It holds approximately 18% market share due to its adaptability across both diagnostic and therapeutic applications. Healthcare providers favor this size for its ease of handling and improved maneuverability during procedures. Around 45% of standard endoscopic interventions utilize mid-sized needles like 22G for consistent results. Enhanced coating technologies have reduced friction during insertion, improving patient safety. Hospitals and clinics both contribute to demand, reflecting its versatile use. Continuous design improvements focus on maintaining precision while enhancing durability. The segment remains a reliable choice for routine procedures across multiple healthcare settings.

Diameter 23G: The 23G segment is one of the most widely used categories due to its optimal balance between precision and injection efficiency. It accounts for nearly 24% of the overall market, making it a dominant product type. These needles are commonly used in therapeutic procedures requiring controlled delivery of agents. Approximately 52% of procedures involving injection therapy utilize 23G needles due to their reliability. Their flexibility allows better navigation through complex anatomical structures. Manufacturers are enhancing needle sharpness and coating to improve penetration efficiency. The segment benefits from high adoption in both hospitals and outpatient settings. Continuous innovation is improving performance and reducing procedural complications.

Diameter 25G: The 25G segment is widely preferred for high-precision procedures where minimal tissue disruption is required. It holds about 25% market share, making it one of the leading segments. These needles are commonly used in delicate procedures, offering improved patient comfort and faster recovery. Around 48% of precision-focused interventions rely on smaller gauge needles such as 25G. Their thin structure enhances maneuverability and reduces resistance during insertion. Clinics increasingly adopt this size due to its efficiency in outpatient procedures. Manufacturers are focusing on improving flexibility without compromising strength. The segment continues to grow due to rising demand for minimally invasive techniques.

Diameter 26G: The 26G segment is designed for highly specialized procedures requiring extreme precision and minimal injection volume. It represents approximately 11% of the market, reflecting its niche application. These needles are commonly used for targeting small lesions and sensitive tissues. Around 29% of advanced diagnostic procedures utilize finer gauge needles like 26G. Their ultra-thin design reduces patient discomfort and enhances procedural accuracy. However, durability remains a challenge, limiting widespread adoption. Specialized healthcare centers primarily use this segment due to its technical requirements. Ongoing innovations aim to improve structural strength while maintaining precision. The segment continues to gain traction in advanced medical applications.

Others: Other needle types include customized and application-specific designs catering to unique clinical requirements. This segment accounts for approximately 10% of the market, driven by innovation and specialized use cases. These needles are often used in research and complex procedures requiring tailored solutions. Around 21% of product development efforts focus on creating customized needle configurations. Adoption is increasing in advanced healthcare facilities with specialized treatment capabilities. Manufacturers are exploring new materials and coatings to enhance performance. The segment benefits from ongoing innovation and expanding clinical applications. Although smaller in share, it plays a critical role in addressing specific medical needs.

By Application

Hospitals: Hospitals dominate the Endoscopic Injection Needle Market Market due to high patient volume and availability of advanced medical infrastructure. This segment holds approximately 62% market share, reflecting its central role in endoscopic procedures. Large hospitals perform a significant portion of the global 75 million endoscopic procedures annually. The presence of skilled professionals and advanced equipment supports complex interventions. Hospitals prefer high-quality, reliable devices to ensure patient safety and procedural efficiency. Continuous investments in healthcare infrastructure further strengthen this segment. Adoption of disposable needles is increasing to meet infection control standards. The segment remains the primary driver of overall market demand.

Clinics: Clinics represent a growing segment in the market, accounting for nearly 27% share due to increasing outpatient procedures. Approximately 31% of endoscopic treatments are now performed in clinic settings, reflecting a shift toward cost-effective healthcare delivery. Clinics prefer compact and easy-to-use devices for quick procedures. The adoption of minimally invasive techniques is driving demand in this segment. Technological advancements have improved device portability and efficiency. Clinics are increasingly equipped with advanced endoscopic systems, supporting wider adoption. The segment benefits from rising patient preference for shorter hospital stays. Growth continues as healthcare systems emphasize outpatient care models.

Others: Other applications include ambulatory surgical centers and specialized research facilities, contributing approximately 11% of the market. These settings are gaining importance due to increasing demand for specialized and targeted treatments. Around 19% of new healthcare facilities are integrating advanced endoscopic technologies. These centers focus on efficiency and precision, supporting niche applications. Adoption is driven by advancements in medical technology and growing healthcare access. Manufacturers are developing products tailored to these settings. The segment is expected to expand as healthcare delivery models evolve. It plays a supportive yet increasingly significant role in the market.

Endoscopic Injection Needle Market Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America is a mature and technologically advanced market characterized by high adoption of minimally invasive procedures and strong healthcare infrastructure. The region benefits from widespread availability of advanced endoscopic equipment and skilled professionals. The United States leads regional demand due to high procedure volumes and well-established healthcare systems. North America accounts for approximately 28% of the global market share, reflecting its strong but stable position. Over 6,000 surgical centers operate across the region, supporting large-scale procedural capacity. Endoscopic procedures exceed 20 million annually, driving consistent demand for injection needles.

Hospitals dominate usage, supported by strong investment in healthcare infrastructure. Technological innovation continues to improve device precision and patient outcomes. Regulatory frameworks ensure high product quality and safety standards. Disposable needle adoption is increasing due to infection control requirements. Collaborations between manufacturers and healthcare providers support product development. The region also emphasizes early diagnosis and preventive care, increasing procedure volumes. Continuous investment in research enhances technological advancement. Supply chain improvements are reducing dependency on imports. Overall, North America remains a key innovation hub in the market.

Europe

Europe represents a well-established market driven by strong regulatory frameworks and increasing adoption of advanced medical technologies. The region focuses on patient safety, efficiency, and sustainability in healthcare delivery. Europe holds approximately 21% market share, supported by high procedural volumes across major countries. More than 15 million endoscopic procedures are performed annually, contributing to steady demand. Countries such as Germany and France lead regional adoption due to advanced healthcare systems. Hospitals and clinics both contribute to demand, reflecting balanced healthcare distribution.

The region emphasizes the use of disposable devices to reduce infection risks. Investments in healthcare infrastructure continue to support growth. Collaborative research initiatives are driving innovation in medical devices. Technological advancements are improving device performance and reliability. Regulatory standards ensure consistent product quality across the region. Aging population trends are increasing demand for gastrointestinal procedures. Healthcare policies support early diagnosis and treatment. The market benefits from strong public healthcare systems. Europe continues to focus on improving efficiency and patient outcomes.

Asia-Pacific

Asia-Pacific is the fastest-growing region in the Endoscopic Injection Needle Market Market due to expanding healthcare infrastructure and large patient population. The region dominates with approximately 42% global market share, reflecting its strong manufacturing and consumption base. China and Japan are major contributors, supported by high procedural volumes exceeding 30 million annually. Rapid urbanization and increasing healthcare investments are driving demand. Hospitals are expanding capabilities to accommodate growing patient volumes. Cost-effective manufacturing supports competitive pricing and wider adoption.

Government initiatives are improving healthcare access across the region. Clinics and outpatient centers are also growing rapidly. Technological advancements are enhancing device quality and performance. The region benefits from strong supply chain networks. Increasing awareness of early diagnosis is driving procedure volumes. Investment in medical infrastructure continues to rise. Local manufacturers are expanding production capacity. Asia-Pacific remains the largest and most dynamic market globally.

Middle East & Africa

The Middle East & Africa region is an emerging market characterized by growing healthcare investments and infrastructure development. The region accounts for approximately 9% of the global market share, reflecting its developing status. Countries such as UAE and Saudi Arabia are leading adoption due to increased healthcare spending. Endoscopic procedures have increased by approximately 24%, indicating rising demand. Hospitals are investing in advanced medical equipment to improve patient care. International collaborations are supporting technology transfer and innovation. Healthcare infrastructure is improving steadily across the region.

The adoption of minimally invasive procedures is increasing. Clinics and specialized centers are expanding capabilities. Government initiatives are promoting healthcare modernization. The region is focusing on improving access to advanced treatments. Demand for disposable devices is rising due to infection control awareness. Investment in training and education is improving procedural outcomes. Supply chain development is enhancing product availability. The market shows strong potential for future growth.

List of Top Endoscopic Injection Needle Market Companies

• Cook Medical
• Boston Scientific
• Steris
• Carbon Medical Technologies
• GI Supply
• Endo-Therapeutics
• Ace Medical Devices
• Conmed
• MTW Endoskopie Manufaktur
• Olympus
• Upex-med
• Changzhou Jiuhong Medical
• AteTec
• Jiangsu Grit Medical

Top Two Companies by Market Share

• Boston Scientific holds approximately 21% market share with strong global distribution and advanced product portfolio.
• Olympus accounts for nearly 19% market share supported by extensive endoscopy expertise and innovation capabilities.

Investment Analysis and Opportunities

Investment in the Endoscopic Injection Needle Market Market is driven by increasing demand for minimally invasive procedures and healthcare infrastructure expansion. Approximately 41% of investments are directed toward research and development, focusing on improving device precision and durability. Healthcare infrastructure projects exceed 320 globally, supporting procedural capacity and device adoption. Strategic partnerships between manufacturers and healthcare providers are increasing, enhancing distribution networks and product accessibility. Government initiatives contribute nearly 34% of total funding, promoting advanced medical technologies. Emerging markets account for approximately 22% of new investment opportunities, reflecting geographic expansion. Additionally, investments in disposable devices are increasing to meet infection control standards. Continuous innovation and funding support are expected to drive long-term market growth.

New Product Development

New product development in the Endoscopic Injection Needle Market Market focuses on improving precision, flexibility, and safety. Approximately 44% of new products incorporate advanced materials to enhance durability and reduce breakage. Needle design improvements have increased procedural accuracy by 30%, supporting better clinical outcomes. Manufacturers are also focusing on ergonomic designs to improve handling and reduce fatigue during procedures. Around 28% of innovations target disposable devices to meet infection control requirements. Integration with advanced endoscopic systems is improving efficiency and compatibility. Additionally, coatings and material enhancements are reducing friction and improving penetration performance. Collaborative research initiatives are accelerating innovation and product launches, supporting market expansion.

Five Recent Developments (2023-2025)

• In 2023, Boston Scientific introduced enhanced injection needle improving precision by 25%.
• In 2023, Olympus expanded production capacity by 18% to meet global demand.
• In 2024, Cook Medical launched advanced disposable needles reducing infection risk by 30%.
• In 2025, Conmed improved needle flexibility by 22% for complex procedures.
• In 2025, Steris expanded distribution networks across 15 new regions.

Report Coverage of Endoscopic Injection Needle Market Market

The report on the Endoscopic Injection Needle Market Market provides comprehensive insights into industry trends, segmentation, and competitive landscape. It analyzes over 45 manufacturers and evaluates multiple product categories across global markets. The study covers 3 major application segments and various needle types, offering detailed insights into demand patterns. Regional analysis spans 4 key geographic areas, highlighting differences in adoption and infrastructure. The report includes evaluation of technological advancements, product innovations, and investment trends. Additionally, it examines supply chain dynamics and regulatory frameworks influencing market growth. Over 30 key statistical indicators are used to ensure data accuracy and reliability. The coverage provides a structured and data-driven understanding of the market.